Show simple item record

dc.contributor.authorMaher, Eamonn R.
dc.contributor.authorAdlard, Julian
dc.contributor.authorBarwell, Julian
dc.contributor.authorBrady, Angela F.
dc.contributor.authorBrennan, Paul
dc.contributor.authorCook, Jackie
dc.contributor.authorCrawford, Gillian S.
dc.contributor.authorDabir, Tabib
dc.contributor.authorDavidson, Rosemarie
dc.contributor.authorDyer, Rebecca
dc.contributor.authorHarrison, Rachel
dc.contributor.authorForde, Claire
dc.contributor.authorHalliday, Dorothy
dc.contributor.authorHanson, Helen
dc.contributor.authorHay, Eleanor
dc.contributor.authorHiggs, Jenny
dc.contributor.authorJones, Mari
dc.contributor.authorLalloo, Fiona
dc.contributor.authorMiedzybrodzka, Zosia
dc.contributor.authorOng, Kai Ren
dc.contributor.authorPelz, Frauke
dc.contributor.authorRuddy, Deborah
dc.contributor.authorSnape, Katie
dc.contributor.authorWhitworth, James
dc.contributor.authorSandford, Richard N.
dc.date.accessioned2024-02-07T08:19:01Z
dc.date.available2024-02-07T08:19:01Z
dc.date.issued2022-05-18
dc.identifier214987313
dc.identifier9d0bb60e-8223-437e-95a8-aed0983fef9e
dc.identifier000757918300002
dc.identifier85124725159
dc.identifier.citationMaher , E R , Adlard , J , Barwell , J , Brady , A F , Brennan , P , Cook , J , Crawford , G S , Dabir , T , Davidson , R , Dyer , R , Harrison , R , Forde , C , Halliday , D , Hanson , H , Hay , E , Higgs , J , Jones , M , Lalloo , F , Miedzybrodzka , Z , Ong , K R , Pelz , F , Ruddy , D , Snape , K , Whitworth , J & Sandford , R N 2022 , ' Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service ' , British Journal of Cancer , vol. 126 , pp. 1339–1345 . https://doi.org/10.1038/s41416-022-01724-7en
dc.identifier.issn0007-0920
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/20107
dc.descriptionAcknowledgements We acknowledge support from the NIHR UK Rare Genetic Disease Research Consortium. We also thank the many individuals who contributed to VHL clinical services in Leicester (Corrina Powell, Vanita Jivanji and Mark C Dalby), Manchester (Zerin Hyder, Ruth Heaton), North West Thames Regional Genetics Service (Lauren Limb), Wessex Clinical Genetics Service (Professor Diana Eccles), West Midlands Clinical Genetics Service (Sue Carless). We thank VHL Alliance UK fpatient support group or their help in designing the audit. Funding We thank the NIHR Cambridge Biomedical Research Centre and VHL Alliance UK for funding research into VHL disease. The University of Cambridge has received salary support (ERM, RNS) from the NHS in the East of England through the Clinical Academic Reserve. The views expressed are those of the authors and not necessarily those of the NHS or Department of Health.en
dc.format.extent7
dc.format.extent669463
dc.language.isoeng
dc.relation.ispartofBritish Journal of Canceren
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectGERMLINE MUTATIONSen
dc.subjectGENETIC REGISTERen
dc.subjectSUPPRESSOR GENEen
dc.subjectNATURAL-HISTORYen
dc.subjectHEMANGIOBLASTOMASen
dc.subjectIDENTIFICATIONen
dc.subjectMANAGEMENTen
dc.subjectFEATURESen
dc.subjectR Medicine (General)en
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectSupplementary Informationen
dc.subject.lccR1en
dc.subject.lccRC0254en
dc.titleEvaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health serviceen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Genetics Groupen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1038/s41416-022-01724-7
dc.identifier.vol126en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record